Drug transfer into target helminth parasites

Trends in Parasitology

Volumn 23, Issue 3, 2007, Pages 97-104

  Alvarez, Luis I ^a,b   Mottier, M Lourdes ^a,b   Lanusse, Carlos E ^a,b  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; ANTHELMINTIC AGENT; AVERMECTIN; CLOSANTEL; FENBENDAZOLE; LEVAMISOLE; MILBEMYCIN; OXFENDAZOLE; TRICLABENDAZOLE;

ARTICLE; CESTODE; CUTICLE; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG TARGETING; HELMINTH; INTEGUMENT; NEMATODE; NONHUMAN; PARASITE CONTROL; PARASITOSIS; TREMATODE; WORM TEGUMENT;

ANIMALS; ANTHELMINTICS; BIOLOGICAL TRANSPORT; DIFFUSION; DRUG RESISTANCE; HELMINTHIASIS; HELMINTHS;

CESTODA; NEMATODA; TREMATODA; VERMES;

EID: 33847048131     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2007.01.003     Document Type: Article

References (50)

1. Waller P. Global perspectives on nematode parasite control in ruminant livestock: the need to adopt alternatives to chemotherapy, with emphasis on biological control. Anim. Health Res. Rev. 4 (2003) 35-43
2. Colley D., et al. Medical helminthology in the 21st century. Science 293 (2001) 1437-1438
3. Thompson D., et al. Mechanistic approaches to quantitate anthelmintic absorption by gastrointestinal nematodes. Parasitol. Today 9 (1993) 31-35
4. Thompson D., and Geary T. Helminth surfaces: structural, molecular and functional properties. In: Marr J., et al. (Ed). Molecular Medical Parasitology (2003), Academic Press 297-338
5. Ho N., et al. Mechanistic studies in the transcuticular delivery of antiparasitic drugs II: ex vivo/in vitro correlation of solute transport by Ascaris suum. Mol. Biochem. Parasitol. 52 (1992) 1-14
6. Verhoeven H., et al. Uptake and distribution of levamisole in Ascaris suum. In: Van den Bossche H. (Ed). Biochemistry of Parasites and Host-Parasite Relationships (1980), Elsevier 473-579
7. Cross H., et al. In vitro uptake of ivermectin by adult male Onchocerca ochengi. Ann. Trop. Med. Parasitol. 92 (1998) 711-720
8. Mottier L., et al. Drug transport mechanism in helminth parasites: passive diffusion of benzimidazole anthelmintics. Exp. Parasitol. 113 (2006) 49-57
9. Alvarez L., et al. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetics behaviour in sheep. J. Vet. Pharmacol. Ther. 22 (1999) 77-86
10. Alvarez L., et al. Uptake of albendazole and albendazole sulphoxide by Haemonchus contortus and Fasciola hepatica in sheep. Vet. Parasitol. 94 (2000) 75-89
11. Alvarez L., et al. Ex vivo diffusion of albendazole and its sulphoxide metabolite into Ascaris suum and Fasciola hepatica. Parasitol. Res. 87 (2001) 929-934
12. Ho N., et al. Biophysical transport properties of the cuticle of Ascaris suum. Mol. Biochem. Parasitol. 41 (1990) 153-165
13. Fetterer R., and Rhoads M. Biochemistry of the nematode cuticle: relevance to parasitic nematodes of livestock. Vet. Parasitol. 46 (1993) 103-111
14. Geary T., et al. Biological functions of nematode surfaces. In: Bothroyd J., and Komuniecki R. (Eds). Molecular Approaches to Parasitology (1995), Wiley-Liss 57-76
15. Sheehy B., et al. Transport of model peptides across Ascaris suum cuticle. Mol. Biochem. Parasitol. 105 (2000) 39-49
16. McKellar Q., and Scott E. The benzimidazole anthelmintic agents - a review. J. Vet. Pharmacol. Therap. 13 (1990) 223-247
17. Mottier M., et al. Transtegumental diffusion of benzimidazole anthelmintics into Moniezia benedeni: correlation with their octanol-water partition coefficients. Exp. Parasitol. 103 (2003) 1-7
18. Geary T., et al. Haemonchus contortus: ivermectin-induced paralysis of the pharynx. Exp. Parasitol. 77 (1993) 88-96
19. Smith H., and Campbell W. Effect of ivermectin on Caenorhabditis elegans larvae previously exposed to alcoholic immobilization. J. Parasitol. 82 (1996) 187-188
20. Sheriff, et al. Effect of ivermectin on feeding by Haemonchus contortus in vivo. Vet. Parasitol. 128 (2005) 341-346
21. Freeman A., et al. Amphidial structure of ivermectin-resistant and susceptible laboratory and field strains of Haemonchus contortus. Vet. Parasitol. 110 (2003) 217-226
22. Dent J., et al. The genetics of ivermectin resistance in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 2674-2679
23. Geary T., et al. Frontiers in anthelmintic pharmacology. Vet. Parasitol. 84 (1999) 275-295
24. Martin R. Electrophysiological effects of anthelmintics in the parasitic nematode Ascaris suum. Asia Pacific J. Pharmacol. 7 (1992) 231-244
25. Sims S., et al. Mechanisms of microenvironmental pH regulation in the cuticle of Ascaris suum. Mol. Biochem. Parasitol. 53 (1992) 135-148
26. Lanusse C., and Prichard R. Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. Drug Metab. Rev. 25 (1993) 235-279
27. Sims S., et al. Influence of organic acid excretion on cuticle pH and drug absorption by Haemonchus contortus. Int. J. Parasitol. 26 (1996) 25-35
28. Uglem G. Water balance and its relation to fermentation acid production in the intestinal parasites Hymenolepis diminuta (Cestoda) and Moniliformis moniliformis (Acanthocephala). J. Parasitol. 77 (1991) 874-883
29. Rothwell J., and Sangster N. Haemonchus contortus: the uptake and metabolism of closantel. Int. J. Parasitol. 27 (1997) 313-319
30. Michiels M., et al. The metabolism and fate of closantel (Flukiver) in sheep and cattle. Drug Metab. Rev. 18 (1987) 235-251
31. Marriner S., and Bogan J. Pharmacokinetics of albendazole in sheep. Am. J. Vet. Res. 41 (1980) 1126-1129
32. Lanusse C., et al. Gastrointestinal distribution of albendazole metabolites following netobimin administration to cattle: relationship with plasma disposition kinetics. J. Vet. Pharmacol. Ther. 16 (1993) 38-47
33. Mottier L., et al. Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidised metabolites into Fasciola hepatica. Xenobiotica 34 (2004) 1043-1057
34. Fetterer R., and Rew R. Interaction of Fasciola hepatica with albendazole and its metabolites. J. Vet. Pharmacol. Ther. 7 (1984) 113-118
35. Alvarez L., et al. Comparative assessment of the access of albendazole, fenbendazole and triclabendazole to Fasciola hepatica: effect of bile in the incubation medium. Parasitology 128 (2004) 73-81
36. Meaney M., et al. A scanning electron microscope study on the route of entry of clorsulon into the liver fluke, Fasciola hepatica. Parasitol. Res. 95 (2005) 117-128
37. Meaney M., et al. Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica. Parasitol. Res. 95 (2005) 201-212
38. Hennessy D., et al. The effect of a short-term reduction in feed on the pharmacokinetics and efficacy of albendazole in sheep. Aust. Vet. J. 72 (1995) 29-30
39. Moreno L., et al. Dose-dependent activity of albendazole against benzimidazole-resistant nematodes in sheep: relationship between pharmacokinetics and efficacy. Exp. Parasitol. 106 (2004) 150-157
40. Sanchez Bruni S., et al. Changes to oxfendazole chiral kinetics and anthelmintic efficacy induced by piperonyl butoxide in horses. Equine Vet. J. 37 (2005) 257-262
41. Alvarez L., et al. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes. Parasitology 131 (2005) 501-510
42. Mottier, L. et al. Resistance induced changes on TCBZ-transport in Fasciola hepatica: ivermectin reversal effect. J. Parasitol. (in press)
43. Solana H., et al. Comparative metabolism of albendazole and albendazole sulphoxide by different helminth parasites. Parasitol. Res. 87 (2001) 275-280
44. Robinson M., et al. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitol. Res. 92 (2004) 205-210
45. Gerlach J., et al. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggest a model for multidrug resistance. Nature 324 (1986) 485-489
46. Pouliot J., et al. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochem. Pharmacol. 53 (1997) 17-25
47. Xu M., et al. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Mol. Biochem. Parasitol. 91 (1998) 327-335
48. Kerboeuf D., et al. P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance. Int. J. Antimicrob. Agents 22 (2003) 332-346
49. Wolstenholme A., et al. Drug resistance in veterinary parasites. Trends Parasitol. 20 (2004) 469-476
50. Reed M., et al. Developmental expression of a Fasciola hepatica sequence homologous to ABC transporters. Int. J. Parasitol. 28 (1998) 1375-1381